Ferula gummosa in colorectal cancer: a bioinformatics and experimental validation study
Research in Pharmaceutical Sciences · 2026-05 · 21 (3) · 346-363
DOI: 10.4103/rps.rps_246_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Pharmaceutical Sciences, online erschienen am 10.05.2026. Verfasst von Abbas Alibakhshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute (AHRI), Hamadan University of Medical Sciences, Hamad…. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose: Colorectal cancer (CRC) is a significant global health challenge, necessitating a comprehensive molecular understanding for personalized treatments. Molecular profiling has elucidated key biomarkers that are essential for prognosis, treatment responsiveness, and targeted therapeutic interventions. Experimental approach: This study explored the role of indigenous phytochemicals, using bioinformatics and experimental assays to identify potential CRC-specific therapeutic targets. Findings/Results: A system biology and drug-target network analysis identified four proteins (ANG, DPP4, INSR, and MAPK14) as potential targets for further investigation. Molecular docking studies showed that the cauferoside from Ferula gummosa has a strong binding affinity for these proteins. Molecular dynamics simulations confirmed the stability of the compound-protein complexes. In vitro assays demonstrated the cytotoxic effects of F. gummosa extracts on CRC cells. The leaf extract significantly downregulated the expression of the ANG , DPP4 , INSR , and MAPK14 genes, while the root extract exhibited differential effects on gene expression. Conclusion and implications: The findings suggest the potential therapeutic efficacy of F. gummosa against CRC and emphasize the importance of a dual methodology involving bioinformatics and experimental validation in drug discovery. Further in vivo and clinical studies are warranted to validate these findings and facilitate potential therapeutic applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute (AHRI), Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
- Cancer Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
- Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, I.R. Iran.
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan 65178-38678, I.R. Iran.
- Department of Horticulture, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, I.R. Iran.
- Department of Food Chemistry and Biocatalysis, Wroclaw University of Life Sciences, 50-375 Wroclaw, Poland.
Zitieren
APA
Alibakhshi, A., Gharibi, S., Shojaeian, A., Asgari, A., Amini, R., Rahimmalek, M., Ahangarzadeh, S., & Szumny, A. (2026). Ferula gummosa in colorectal cancer: a bioinformatics and experimental validation study. Research in Pharmaceutical Sciences, 21(3), 346-363. https://doi.org/10.4103/rps.rps_246_24
Vancouver
Alibakhshi A, Gharibi S, Shojaeian A, Asgari A, Amini R, Rahimmalek M, et al. Ferula gummosa in colorectal cancer: a bioinformatics and experimental validation study. Research in Pharmaceutical Sciences. 2026;21(3):346-363. doi:10.4103/rps.rps_246_24
BibTeX
@article{Alibakhshi2026,
author = {Alibakhshi, Abbas and Gharibi, Shima and Shojaeian, Ali and Asgari, Atefeh and Amini, Razieh and Rahimmalek, Mehdi and Ahangarzadeh, Shahrzad and Szumny, Antoni},
title = {Ferula gummosa in colorectal cancer: a bioinformatics and experimental validation study},
journal = {Research in Pharmaceutical Sciences},
year = {2026},
volume = {21},
number = {3},
pages = {346--363},
doi = {10.4103/rps.rps_246_24}
}
EUVIMED